Training for Academic Hematology

此申请是为大卫·格芬的PHS机构国家服务奖进行竞争性续签 加州大学洛杉矶分校医学院为血液学的学术生涯做准备。这个奖项是 成立于2002年7月，并支持血液学/内科肿瘤学2年级和3年级的4个奖学金名额 训练。在参加该方案的11名研究员中，4名目前正在接受培训，7名已完成学业。 奖学金，其中4人是加州大学洛杉矶分校的全职教员，两人正在与产业界进行临床试验开发， 其中一例已进入临床实践。学院由31名学术科学家和内科医生组成， 分为四个共同研究领域，造血学和干细胞生物学(Kenneth 多什金德，博士，主任)，白血病(加里·席勒，医学博士，主任)，淋巴细胞生物学和淋巴瘤 (艾伦·利希滕斯坦，医学博士，主任)和止血、血栓和血管生物学(维克托·马德，医学博士， 董事)。所有教员都有校外研究补助金，其中24人(77%)有NIH补助金。 与互补学科的其他培训计划的互动强调了我们的互动目标 基础研究和翻译研究的职业。每年春天都会举行一次研究务虚会，在此期间， Mentor介绍了实验室的研究兴趣的概述，然后是各自的报告 伙伴们的进步。对导师的有效性以及研究员的进步和目标的正式审查是 由指导委员会编写，由四位重点主任组成。为所有人提供了一门核心课程 研究员，包括“临床研究课程”，该课程涵盖研究设计和分析的主题， 道德、监管、问题、拨款准备和负责任的研究行为。我们鼓励研究人员 作为STAR计划的一部分获得高级学位，并在适当的正规课程中工作 各部门再延长一到两年时间。在完成课程的7名研究员中， 2002年至今，2人获得硕士学位，1人获得博士学位。培训 拥有基础、临床和转化性研究专业知识的血液学家是 加州大学洛杉矶分校的大卫·格芬医学院，这一申请寻求支持 临床培训和最终的血液学学术生涯。

This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was nitiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). All the faculty have extramural research grant support, including 24 (77%) with NIHgrants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory,issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.